单病例随机对照试验在中医药研究中的可行性与潜在价值  

Potential value and feasibility of N-of-1 randomized controlled trials in research of traditional Chinese medicine

作　　者：黄海茵[1] 杨佩兰[1] 张誉清[2] 薛晶晶[1] 徐敏华[1] 

机构地区：[1]上海中医药大学附属岳阳中西医结合医院,上海200437 [2]加拿大麦克马斯特大学临床流行病与生物统计学系

出　　处：《上海中医药杂志》2012年第8期3-8,共6页Shanghai Journal of Traditional Chinese Medicine

基　　金：上海市名老中医学术经验研究工作室建设项目(ZYSNXD-CC-MZY029)

摘　　要：单病例随机对照试验的个体化治疗理念与中医辨证论治有相通之处,对于中医药研究可能是一个很好的方法;根据单病例随机对照试验的原理与方法,探讨其应用于中医药临床研究的可行性及潜在价值。N-of-1 randomized controlled trials（RCT） may be a promising method of evidence-based medicine for the research of traditional Chinese medicine. The idea of individualized treatment reflected by N-of-1 RCT accords with treatment based on syndrome differentiation. This paper investigated into the principles and methods of N-of-1 RCT to explore the feasibility and potential value in the clinical research of traditional Chinese medicine.

关 键 词：随机对照试验 单病例 中医学 

分 类 号：R24[医药卫生—中医临床基础]